InfoMedSearch Newsletters
CAM

:: September 2014


Welcome to our Monthly Online Newsletter!


Highlighted Articles

Our Highlighted Articles are now being included in our Weekly Featured Articles site. If you have not already signed up for our Alerts newsletter which links to this site, please do so at our sign up page. Stay current and save time. Free access to our Weekly Featured Articles and Weekly Featured Brain Articles.

Guidelines

See Internet sites listed below

Internet Sites

Related InfoMedSearch Topics

Related Topics - Highlighted Articles

Supplements - Nutrition

Essential nutrients: food or supplements? Where should the emphasis be? (JAMA. 2005) "The consumption of adequate levels and proper balance of essential nutrients is critical for maintaining health. The identification, isolation, and purification of nutrients in the early 20th century raised the possibility that optimal health outcomes could be realized through nutrient supplementation. Recent attempts using this approach for cardiovascular disease and lung cancer have been disappointing, as demonstrated with vitamin E and beta carotene. Moreover, previously unrecognized risks caused by nutrient toxicity and nutrient interactions have surfaced during intervention studies. The most promising data in the area of nutrition and positive health outcomes relate to dietary patterns, not nutrient supplements."


Vitamins

Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. (J Am Coll Cardiol. 2005) "OBJECTIVES: The aim of this research was to estimate the efficacy and safety of current high-density lipoprotein cholesterol (HDL-C)-increasing drugs. CONCLUSIONS: Fibrates reduce major coronary events and increase HDL-C levels without significant toxicity. Niacin has a more potent effect on HDL-C levels, whereas data on cardiovascular event rate reduction are limited. Future studies need to evaluate whether additional HDL increase by fibrates or particularly newer niacin formulations on top of statin therapy translates into further event reduction in high-risk subjects, without significant toxicity."

 

In this newsletter:
General Information

 

© 2004-2010 InfoMedSearch, LLC. All Rights Reserved. | Design: mqstudio | Disclaimer